SEC Filings
Merck's Lead-Director Handoff Will Precede Its Current Director's Planned May Retirement
A board member since 2022, the incoming independent lead director formerly chaired and ran Ecolab.
Merck (MRK) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
A board member since 2022, the incoming independent lead director formerly chaired and ran Ecolab.
Earnings
Executives called the affected markets small and said Qlex sales reached $830 million in the quarter, mostly in the U.S.
Earnings
Rob Davis pointed to an acquisition, a PD-1/VEGF drug and a stronger cancer vaccine profile that the original $70 billion figure missed.
Earnings
Third-quarter adjusted earnings per share fell to $2.49 from $2.58, yet the drugmaker raised its full-year range.
SEC Filings
Diaz joins November 1 and will sit on the Audit and Research committees, with a shareholder vote due in May 2027.